Merck & Co., Inc: all 2,453 studies
Page 16 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)CompletedNCT00160251Phase 2Results posted
- Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)CompletedNCT00157950Phase 3Results posted
- A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)CompletedNCT00132769Phase 2Results posted
- An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)TerminatedNCT00132730Phase 2Results posted
- Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)CompletedNCT00130832Phase 3Results posted
- A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)CompletedNCT00130793Phase 3Results posted
- Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)CompletedNCT00128102Phase 3Results posted
- A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)CompletedNCT00127192Phase 2Results posted
- A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029)CompletedNCT00127127Phase 1Results posted
- An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)TerminatedNCT00127101Phase 1Results posted
- A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)CompletedNCT00124735Phase 3Results posted
- A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)CompletedNCT00112437Phase 2Results posted
- Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))CompletedNCT00111813Phase 1Results posted
- V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)CompletedNCT00109343Phase 3Results posted
- Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)CompletedNCT00106704Phase 3Results posted
- Suberoylanilide Hydroxamic Acid in Advanced Solid TumorsCompletedNCT00106626Phase 1Results posted
- Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)CompletedNCT00105534Phase 3Results posted
- Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)CompletedNCT00105469Phase 3Results posted
- Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)CompletedNCT00105157Phase 2Results posted
- Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)CompletedNCT00104052Phase 3Results posted
- MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)CompletedNCT00103857Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)CompletedNCT00100048Phase 2Results posted
- Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)TerminatedNCT00095576Phase 2Results posted
- An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)CompletedNCT00095056Phase 3Results posted
- An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)CompletedNCT00094770Phase 3Results posted
- An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)CompletedNCT00094757Phase 3Results posted
- A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)CompletedNCT00092547Phase 3Results posted
- Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)CompletedNCT00092534Phase 3Results posted
- Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)CompletedNCT00092521Phase 3Results posted
- Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)CompletedNCT00092495Phase 3Results posted
- Consistency Lots Vaccine Study (V260-009)CompletedNCT00092456Phase 3Results posted
- Dose Confirmation Efficacy Study (V260-007)CompletedNCT00092443Phase 3Results posted
- Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)CompletedNCT00092417Phase 3Results posted
- Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)CompletedNCT00091572Phase 3Results posted
- An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)CompletedNCT00090285Phase 3Results posted
- Rotavirus Efficacy and Safety Trial (REST)(V260-006)CompletedNCT00090233Phase 3Results posted
- A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)CompletedNCT00090220Phase 3Results posted
- Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)CompletedNCT00087516Phase 3Results posted
- Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)CompletedNCT00086515Phase 3Results posted
- Pioglitazone Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT00086502Phase 3Results posted
- Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)CompletedNCT00081770Phase 3Results posted
- Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)CompletedNCT00049842Phase 3Results posted
- Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)CompletedNCT00048724Phase 3Results posted
- PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)CompletedNCT00039871Phase 3Results posted
- A Clinical Trial to Evaluate [14C]-MK-4208/[14C]-TERN-701 in Healthy Adult Male Participants (MK-4208-002/TERN701-1016)CompletedNCT07839000Phase 1
- A Clinical Trial to Evaluate MK-4208/Embibatinib in Healthy Adult Participants (MK-4208-001/Embibatinib-1014)CompletedNCT07838987Phase 1
- A Clinical Trial to Evaluate the Effects of MK-4646 on Rosuvastatin in Healthy Participants (MK-4646-007)Active, not recruitingNCT07785830Phase 1
- A Clinical Trial of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-044)Active, not recruitingNCT07776665Phase 1
- A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)Active, not recruitingNCT07748351Phase 1
- A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)CompletedNCT07697625Phase 1
- A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)CompletedNCT07677163Phase 1
- A Clinical Study of MK-8527 in Healthy Participants (MK-8527-021)CompletedNCT07661108Phase 1
- A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)CompletedNCT07619443Phase 1
- A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)CompletedNCT07595263Phase 1
- A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017)CompletedNCT07548606Phase 1
- A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646)CompletedNCT07532304Phase 1
- A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)CompletedNCT07530289Phase 1
- A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527 on Levels of Methadone (MK-8527-020)CompletedNCT07528508Phase 1
- Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Active, not recruitingNCT07486960Phase 2
- A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)CompletedNCT07481708Phase 1
- A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)CompletedNCT07435194Phase 1
- A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)CompletedNCT07431866Phase 1
- A Study of MK-7240 in Healthy Participants (MK-7240-009)CompletedNCT07405177Phase 1
- A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)CompletedNCT07388667Phase 1
- A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)CompletedNCT07348237Phase 1
- A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)CompletedNCT07334886Phase 1
- A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)CompletedNCT07334860Phase 1
- A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)CompletedNCT07305831Phase 1
- A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)CompletedNCT07300280Phase 1
- A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)CompletedNCT07266818Phase 1
- A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)CompletedNCT07242469Phase 1
- A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)CompletedNCT07232589Phase 1
- A Study of Annual Doses of MK-1406/CD388 in Healthy Adults (MK-1406-006/CD388.SQ.2.07)Active, not recruitingNCT07225959Phase 2
- A Clinical Study of V540A in Healthy Female Participants (V540A-005)WithdrawnNCT07224477Phase 2
- A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)CompletedNCT07222098Phase 1
- A Study of Calderasib (MK-1084) in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017)CompletedNCT07219550Phase 1
- A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)Active, not recruitingNCT07218029Phase 3
- A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)CompletedNCT07216482Phase 3
- A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)CompletedNCT07199452Phase 1
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Active, not recruitingNCT07176390Phase 2
- A Study of V118E in Healthy Participants (V118E-003)Active, not recruitingNCT07168915Phase 1
- A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)Active, not recruitingNCT07133633Phase 2
- A Phase II Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Single Inhaled Doses of Ensifentrine-glycopyrrolate Fixed Dose Combination, Ensifentrine, and Glycopyrrolate in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT07132983Phase 2
- A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)CompletedNCT07121959Phase 1
- Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)CompletedNCT07089784Phase 1
- A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)CompletedNCT07086079Phase 1
- A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)CompletedNCT07063238Phase 1
- A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)CompletedNCT07049939Phase 1
- A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)CompletedNCT07044479Phase 1
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)Active, not recruitingNCT07044297Phase 3
- MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)CompletedNCT07042945Phase 1
- A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)CompletedNCT07025551Phase 1
- Clinical Study of Ensifentrine-Glycopyrrolate (MK-5884A/RPL554) Fixed-dose Combination Dose Ranging in Participants With COPD (MK-5884A-029/RPL554-CO-212)CompletedNCT07016412Phase 2
- A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)Active, not recruitingNCT07013487Phase 3
- A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)Active, not recruitingNCT06961006Phase 2
- A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DMEActive, not recruitingNCT06957080Phase 2/3
- Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)Active, not recruitingNCT06956235Phase 2
- A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)CompletedNCT06942741Phase 1
- A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)CompletedNCT06930664Phase 1
- A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)Active, not recruitingNCT06925750Phase 2